{"id":21821,"date":"2024-01-25T09:00:00","date_gmt":"2024-01-25T08:00:00","guid":{"rendered":"https:\/\/ggba.swiss\/?p=21821"},"modified":"2024-01-24T11:47:28","modified_gmt":"2024-01-24T10:47:28","slug":"biomanufacturing-innovator-stamm-opens-its-european-rd-facility-in-monthey","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/biomanufacturing-innovator-stamm-opens-its-european-rd-facility-in-monthey\/","title":{"rendered":"Biomanufacturing innovator St\u00e4mm opens its European R&D facility in Monthey"},"content":{"rendered":"\n

With the establishment of its new R&D facility in Western Switzerland, St\u00e4mm<\/a> is set to bring its pioneering technology to the heart of Europe’s thriving biotech sector. The new facility at the BioArk<\/a> in Monthey represents a significant step in the company’s global expansion strategy, underscoring its commitment to innovative biomanufacturing processes. St\u00e4mm anticipates the creation of approximately 30 new jobs in the region within the next 3 years, contributing significantly to the local economy and employment landscape.<\/p>\n\n\n\n

This move in the heart of the \u201cHealth Valley\u201d is aligned with St\u00e4mm’s vision to make biomanufacturing more accessible, efficient, and sustainable, thereby addressing some of the most pressing challenges in the biopharmaceutical industry. The strategic location of Monthey offers an ideal environment for St\u00e4mm to collaborate with leading industry players and academic institutions, further propelling their mission to transform bioprocessing through cutting-edge, environmentally conscious technology.<\/p>\n\n\n\n

Juan Mart\u00edn Cabaleiro, CTO of St\u00e4mm, with a rich background in mechanical engineering and microfluidics, emphasizes St\u00e4mm’s commitment to making bioprocessing easy, scalable, sustainable, and repeatable. “Our advanced microfluidic systems, inspired by nature\u2019s microvascular networks, are designed to optimize efficiency while minimizing environmental impact. Establishing our presence at BioArk in Monthey aligns perfectly with our mission,” says Cabaleiro. The decision to establish a presence in Switzerland, particularly in the canton of Valais, was driven by the region’s robust biomanufacturing ecosystem and its proximity to top-tier academic institutions and key European markets. “The central location in Europe, coupled with the local industry and academic expertise, makes Monthey an ideal spot for our innovative pursuits,” adds Cabaleiro.<\/p>\n\n\n\n

Support from GGBa, Economic Promotion Valais, and the Swiss Biotech Center<\/h4>\n\n\n\n

The establishment of St\u00e4mm in Switzerland is the result of a proactive approach by the Greater Geneva Bern area (GGBa<\/a>), which supported it throughout the process in collaboration with Promotion \u00c9conomique Valais<\/a> and the Swiss Biotech Center<\/a>. Yassin Nahi from GGBa and Massimo Nobile from the Swiss Biotech Center provided essential guidance in establishing St\u00e4mm’s operations, including logistical and networking support. “The welcoming approach and effective assistance from these agencies have been invaluable in integrating St\u00e4mm into the Swiss biotech landscape,” notes Cabaleiro.<\/p>\n\n\n\n

St\u00e4mm envisions becoming a catalyst for change in bioprocessing and biomanufacturing within Switzerland. The initial focus will be on collaborative projects with local entities, demonstrating the effectiveness of St\u00e4mm’s Bioprocessors. “Our goal is to solidify our presence and play a pivotal role in Swiss innovation, utilizing our strategic position to expand across Europe,” Cabaleiro concludes.<\/p>\n\n\n\n

\n